Coagulation and immune function indicators for monitoring of coronavirus disease 2019 and the clinical significance. / 2019å ç¶ç
æ¯ç
åè¡åå
ç«åè½ææ ççæµå临åºæä¹.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 45(5): 525-529, 2020 May 28.
Article
in English, Chinese
| MEDLINE | ID: covidwho-745331
ABSTRACT
OBJECTIVES:
To explore the significance of coagulation and immune function indicators in clinical diagnosis and treatment of coronavirus disease 2019 (COVID-19).METHODS:
All patients with COVID-19 diagnosed and treated in First People's Hospital of Yueyang from January to March 2020 were enrolled. The general data of patients were collected. The patients were assigned into a light group (n=20), an ordinary group (n=33), a severe group (n=23), and a critically severe group (n=7) according to the severity of the disease. Coagulation and immune function indicators of each group were compared, and the relevance of coagulation and immune function indicators was analyzed.RESULTS:
The age of COVID-19 patients in Yueyang City was mainly between 45 and 65 years old. There was a significant difference in the coagulation function and immune-related indicators in each group of patients (all P<0.05).CONCLUSIONS:
There are some abnormalities in coagulation and immune function in patients with COVID-19, which possess significance for clinical diagnosis and treatment of the disease.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Blood Coagulation
/
Coronavirus Infections
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Aged
/
Humans
/
Middle aged
Country/Region as subject:
Asia
Language:
English
/
Chinese
Journal:
Zhong Nan Da Xue Xue Bao Yi Xue Ban
Journal subject:
Medicine
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS